Latham & Watkins has advised AIR Limited. DLA Piper has advised Cantor Equity Partners III. Wilmer Cutler Pickering Hale and Dorr has advised Barclays. AIR Limited,...
AIR Limited and Cantor Equity Partners III Announce $1.749 Billion Business Combination
Thermo Fisher’s $4.1 Billion Acquisition of Purification and Filtration Business from Solventum
Wilmer Cutler Pickering Hale and Dorr advised Thermo Fisher Scientific Inc. on the transaction, and Cleary Gottlieb Steen & Hamilton and Paksoy advised Solventum. Debevoise &...
Cresset’s Acquisition of CH Investment Partners
Wilmer Cutler Pickering Hale and Dorr represented CH Investment Partners in the transaction. Cresset Asset Management (“Cresset”) , an independent investment firm, announced its acquisition of...
Terns Pharmaceuticals’ $172.7 Million IPO
Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
CorroHealth’s $365 Million Acquisition of Navient’s Healthcare Services Business
Wilmer Cutler Pickering Hale and Dorr represented Navient Corporation in the offering. Navient Corporation (Nasdaq: NAVI), a provider of technology-enabled education finance and business processing solutions,...
Milestone Pharmaceuticals’ $34.5 Million Common Shares Offering
Osler, Hoskin & Harcourt acted as Canadian counsel to Milestone Pharmaceuticals Inc. in the offering, Cooleyacted as US counsel to the company. Wilmer Cutler Pickering Hale...
Linden Capital Partners’ Acquisition of Alcresta Therapeutics
Kirkland & Ellis represented Linden Capital Partners, Wilmer Cutler Pickering Hale and Dorr represented Alcresta Therapeutics and Wilson Sonsini Goodrich & Rosati advised HealthQuest Capital. Linden...
TechTarget’s Combination with Informa
Wilmer Cutler Pickering Hale and Dorr represented TechTarget, Inc. in the transaction, and Clifford Chance represented Informa PLC. TechTarget, Inc. (NASDAQ: TTGT) and Informa PLC (LSE:...